Treatment of a Liver disease with medical cannabis
According to the 2017 CDC Mortality Rates Weekly Report, the death rate from cirrhosis and chronic liver disease expanded by 31% in the United States from 2000 to 2015 among adults 45-64 years of age. The alarming results show that the disease is widespread in the United States and that it must be addressed as quickly as possible.
With medical marijuana, some who suffer from this condition can alleviate their pain and debilitation. In 2018, the journal Medicines published a study titled “The Role of Tetrahydrocannabinol in the Context of Cirrhosis.” Researchers found that the cannabinoid receptors system has been linked to cirrhosis and liver disease, specifically, with intriguing potential therapeutic benefits.
Treatments, Causes, and Symptoms of Liver Disease
Liver disease is just as serious, if not more so than kidney disease. Nausea, Itchy skin, loss of appetite, dark urine, persistent tiredness, vomiting, easy bruising, and ankle, and leg swelling are all symptoms that can be experienced by both types of illness. Lifestyle adjustments are the first line of defense.
Liver disease can be prevented by avoiding alcohol and red meat, as well as by exercising regularly and eating a healthy diet. Alternative medicine and supplements, such as Germander, Vitamin A, Skullcap, and Comfrey, can help to treat liver disease in addition to a healthy lifestyle. Approximately 15 clinical studies for liver disease are also reported by Mayo Clinic.
How Cannabinoids Affect Liver Disease
As previously mentioned, medical cannabis has been shown to have significant benefits for patients with liver disease, according to the journal Medicines. Toxic cannabidiol (THC) inhibits the proliferation of liver myofibroblasts and star cells and causes cell death, a finding that could lead to the discovery of new antifibrotic and hepatoprotective mechanisms. The endocannabinoid system has therapeutic potential in the treatment of cirrhosis.
In 2018, the Publication of the Canadian Association of Gastroenterology published their official mission statement, which stated that while cannabis is legal for recreational use in Canada, it has not yet been prescribed for medical use: :
Some conditions, such as chemotherapy, sleeplessness, HIV/AIDS, cancer, depressed mood, and more, have not reacted to conventional medical therapies, and medical cannabis can help alleviate their symptoms. “Physicians may permit the use of marijuana in different forms of cannabinoid compounds for the relief from symptoms associated with a wide variety of disorders,” according to the statement.
Medical marijuana has been shown to ease the above-mentioned symptoms, as well as inflammation, nausea, appetite loss, and chronic fatigue, all of which are hallmarks of liver disease. Pure Green Chief Medical Officer Dr. Debra Kimless told digidrs in a discussion that stress, poor eating, and insomnia are all contributing factors to America’s inflamed state.
Dr. Kimless explained to digidrs that “everything from skin problems to autoimmune to hypertension, it’s all based on inflammation,” he said. There are many detrimental effects of chronic inflammation on our bodies.
In addition to Dr. Kimless, a 2009 Future Medicative Chemistry report further confirms “cannabinoids as novel anti-inflammatory drugs,” primarily because “cannabinoid CB2, found on cells of the immune system, could regulate the structure.” More patients with liver disease and kidney disease will benefit from medical cannabis research as it has done with the latter, as it does with kidney disease.